【结 构 式】 |
【分子编号】39705 【品名】2-(3-chlorophenyl)acetic acid; 3-chlorophenylacetic acid 【CA登记号】1878-65-5 |
【 分 子 式 】C8H7ClO2 【 分 子 量 】170.59508 【元素组成】C 56.33% H 4.14% Cl 20.78% O 18.76% |
合成路线1
该中间体在本合成路线中的序号:(I)The condensation of labeled 2-(3-chlorphenyl)acetic acid (I) with N-methylethanolamine (II) by means of SOCl2 gives the corresponding amide (III), which is reduced with BH3, yielding the tertiary amine (IV). The reaction of (IV) with PCl3 affords the chloroethylamine (V), which is finally cyclized by means of AlCl3 to provide the target benzazepine.
【1】 Hieble, J.P.; Wilson III, J.W.; Weinstock, J.; The chemistry and pharmacology of 3-benzazepines derivatives. Drugs Fut 1985, 10, 8, 645. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 39705 | 2-(3-chlorophenyl)acetic acid; 3-chlorophenylacetic acid | 1878-65-5 | C8H7ClO2 | 详情 | 详情 |
(I) | 44628 | 2-(3-chlorophenyl)acetic acid | C8H7ClO2 | 详情 | 详情 | |
(II) | 13324 | 2-Methylaminoethanol; 2-(Methylamino)-1-ethanol | 109-83-1 | C3H9NO | 详情 | 详情 |
(III) | 44044 | 2-(3-chlorophenyl)-N-(2-hydroxyethyl)-N-methylacetamide | C11H14ClNO2 | 详情 | 详情 | |
(III) | 44629 | 2-(3-chlorophenyl)-N-(2-hydroxyethyl)-N-methylacetamide | C11H14ClNO2 | 详情 | 详情 | |
(IV) | 44045 | 2-[(3-chlorophenethyl)(methyl)amino]-1-ethanol | C11H16ClNO | 详情 | 详情 | |
(IV) | 44630 | 2-[(3-chlorophenethyl)(methyl)amino]-1-ethanol | C11H16ClNO | 详情 | 详情 | |
(V) | 44046 | 2-chloro-N-(3-chlorophenethyl)-N-methyl-1-ethanamine; N-(2-chloroethyl)-N-(3-chlorophenethyl)-N-methylamine | C11H15Cl2N | 详情 | 详情 | |
(V) | 44631 | 2-chloro-N-(3-chlorophenethyl)-N-methyl-1-ethanamine; N-(2-chloroethyl)-N-(3-chlorophenethyl)-N-methylamine | C11H15Cl2N | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)Alkylation of 3-chlorophenylacetic acid (I) with allyl bromide (II) using lithium hexamethyldisilazide provided racemic (III), which was resolved by recrystallization of the corresponding diastereoisomeric salts with (S)-alpha-methylbenzylamine. The desired (S)-carboxylic acid (IV) was converted to acid chloride and then treated with methylamine yielding amide (V). Reduction of (V) with LiAlH4 gave amine (VI), which was acylated with benzenesulfonyl chloride to afford sulfonamide (VII). A two-step oxidation of the allyl group of (VII) with osmium tetroxide and N-methylmorpholine N-oxide, followed by sodium periodate cleavage of the resulting diol produced aldehyde (VIII). Reductive condensation of (VIII) with spiro piperidine (IX) using NaBH(OAc)3 furnished adduct (X). Final oxidation of the sulfide group of (X) with one equivalent of Oxone(r) afforded the title sulfoxide.
【1】 Meurer, L.C.; Oates, B.; Finke, P.E.; et al.; Discovery of potent human CCR5 antagonists for the treatment of HIV-1 infection. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst MEDI 118. |
【2】 Mills, S.G.; MacCoss, M.; Springer, M.S. (Merck & Co., Inc.); Spiro-substd. azacycles as modulators of chemokine receptor activity. US 5962462; WO 9825605 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 39705 | 2-(3-chlorophenyl)acetic acid; 3-chlorophenylacetic acid | 1878-65-5 | C8H7ClO2 | 详情 | 详情 |
(II) | 11463 | 3-Bromo-1-propene; 3-Bromopropene;allyl bromide | 106-95-6 | C3H5Br | 详情 | 详情 |
(III) | 39706 | 2-(3-chlorophenyl)-4-pentenoic acid | C11H11ClO2 | 详情 | 详情 | |
(IV) | 39707 | (2S)-2-(3-chlorophenyl)-4-pentenoic acid | C11H11ClO2 | 详情 | 详情 | |
(V) | 39708 | (2S)-2-(3-chlorophenyl)-N-methyl-4-pentenamide | C12H14ClNO | 详情 | 详情 | |
(VI) | 39709 | N-[(2S)-2-(3-chlorophenyl)-4-pentenyl]-N-methylamine; (2S)-2-(3-chlorophenyl)-N-methyl-4-penten-1-amine | C12H16ClN | 详情 | 详情 | |
(VII) | 39710 | N-[(2S)-2-(3-chlorophenyl)-4-pentenyl]-N-methylbenzenesulfonamide | C18H20ClNO2S | 详情 | 详情 | |
(VIII) | 39711 | N-[(2S)-2-(3-chlorophenyl)-4-oxobutyl]-N-methylbenzenesulfonamide | C17H18ClNO3S | 详情 | 详情 | |
(IX) | 39712 | C12H15NS | 详情 | 详情 | ||
(X) | 39713 | C29H33ClN2O2S2 | 详情 | 详情 |